Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
467 Among patients with moderately to severely active UC, 40.6% of patients treated with tofacitinib (10 mg twice daily) for 8 weeks achieved significant remission
Conversations with healthcare providers can be re-framed to discuss What Matters to the patients and caregivers
Li S, Wu Y, Zhang J, Sun H, Wang X
Gwyer D, Wragg NM, Wilson SL
Patients were stratified into high- and low-risk groups based on the optimal cutoff value of the choline metabolism-related risk score to assess the prognostic accuracy of the choline metabolism-related signature (222)
US$ 24.65
US$ 23.28
US$ 27.67
US$ 27.28
US$ 21.99
